Publications by authors named "Dinglan Zuo"

Claim this Profile
U
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma.
Yichuan Yuan, Yi Niu, Zhenkun Huang, Yunxing Shi, Zhu Lin, Dinglan Zuo

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.
Zhiwen Yang, Yichuan Yuan, Yi Niu, Dinglan Zuo, Wenwu Liu

Cell Oncol (Dordr)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.
Yunxing Shi, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Yi Niu

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mA-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.
Zhu Lin, Zhenkun Huang, Jiliang Qiu, Yunxing Shi, Dinglan Zuo

J Exp Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APC mice.
Yanhong Lang, Chengrui Zhong, Lingling Guo, Zhijie Liu, Dinglan Zuo

iScience· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
Yongjin Wang, Dinglan Zuo, Zhenkun Huang, Yuxiong Qiu, Zongfeng Wu

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.
Yunxing Shi, Kai Li, Yichuan Yuan, Chenwei Wang, Zhiwen Yang, Dinglan Zuo

Cancer Cell Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
Zhiyu Qiu, Chenwei Wang, Pinzhu Huang, Yichuan Yuan, Yunxing Shi, Dinglan Zuo

Clin Transl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.
Fangfang Bi, Yuxiong Qiu, Zongfeng Wu, Shaoru Liu, Dinglan Zuo

Cell Death Discov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma.
Keren Li, Yi Niu, Kai Li, Chengrui Zhong, Zhiyu Qiu, Dinglan Zuo

J Clin Transl Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Yunxing Shi, Yi Niu, Yichuan Yuan, Kai Li, Chengrui Zhong, Dinglan Zuo

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.
Chengrui Zhong, Yi Niu, Wenwu Liu, Yichuan Yuan, Kai Li, Dinglan Zuo

Adv Sci (Weinh)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3.
Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, Kai Li, Yi Niu

Cell Death Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling.
Kai Li, Yi Niu, Yichuan Yuan, Jiliang Qiu, Yunxing Shi, Dinglan Zuo

Oncogene· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
Chenwei Wang, Yadi Liao, Wei He, Hong Zhang, Dinglan Zuo

J Exp Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.
Yongjin Wang, Yadi Liao, Wenwu Liu, Yuanping Zhang, Yichuan Yuan, Dinglan Zuo

Dig Surg· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma.
Yadi Liao, Chenwei Wang, Zhiwen Yang, Wenwu Liu, Yichuan Yuan, Dinglan Zuo

Theranostics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transition.
Yuanping Zhang, Jiliang Qiu, Dinglan Zuo, Yichuan Yuan, Yuxiong Qiu

FEBS Open Bio· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
Chenwei Wang, Yadi Liao, Wei He, Hong Zhang, Dinglan Zuo

J Exp Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Chenwei Wang, Yadi Liao, Jiliang Qiu, Yichuan Yuan, Yuanping Zhang, Dinglan Zuo

J Cancer Res Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Chenwei Wang, Wei He, Yichuan Yuan, Yuanping Zhang, Kai Li, Dinglan Zuo

Liver Int· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
Zhiwen Yang, Ruhai Zou, Yun Zheng, Jiliang Qiu, Jingxian Shen, Dinglan Zuo

Eur Radiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave ablation resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis.
Wenwu Liu, Ruhai Zou, Chenwei Wang, Jiliang Qiu, Jingxian Shen, Dinglan Zuo

Ther Adv Med Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study.
Wenwu Liu, Zhiwen Yang, Ruhai Zou, Jiliang Qiu, Jingxian Shen, Dinglan Zuo

J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Wenwu Liu, Yun Zheng, Wei He, Ruhai Zou, Jiliang Qiu, Dinglan Zuo

Aliment Pharmacol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis